MS-1819 Completed Phase 2 Trials for Pancreatitis, Chronic / Distal Pancreatectomy (DP) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03481803A Phase IIa Study With Escalating Dose of MS1819-SD